Cronos Group Inc. CRON CRON said Monday it has submitted a Form 12b-25 with the U.S. Securities and Exchange Commission to postpone the date of filing its annual report for 15 days.
The company said it couldn’t finalize its financial report and statements for fiscal 2019 because of an enduring review by its audit committee and outside counsels, which have been thoroughly examining a few bulk resin purchases and product sales via the wholesale channel.
Cronos Group said on Feb. 24 it will postpone the release of its financial results for the fourth quarter and 2019 and investor conference call, which had been set for Feb. 27.
Although the company plans to report its financial results within the extension period of 15 days, it has noted it can’t guarantee it will be able to comply with the new deadline.
Cronos Group shares dropped 6.8%, hitting $5.61 per share in Tuesday’s pre-market session.
Related Links:
Analyst Raises Price Objectives For Cannabis Stocks: 'Higher Multiples Raise The Bar For All'
Edge Rankings
Price Trend
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Cannabis is evolving—don’t get left behind!
Curious about what’s next for the industry and how to stay ahead in today’s competitive market?
Join top executives, investors, and industry leaders at the Benzinga Cannabis Capital Conference in Chicago on June 9-10. Dive deep into market-shaping strategies, investment trends, and brand-building insights that will define the future of cannabis.
Secure your spot now before prices go up—this is where the biggest deals and connections happen!
